ArticleAnnals of internal medicine2020

In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.

Aris Liakos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.